Medicare-aged Americans need a cognitive care plan
Prolong independence with personalized cognitive care
76% of patients using a RestoreU care plan showed steady or improved memory results
COGNITIVE CARE CHECKLIST
By the numbers
Drugs that failed to gain FDA approval in the past 20 years
Years of research showing disease progression can be halted by managing treatable risk factors
Known causes of cognitive decline
of active risk factors are addressed by RestoreU care plans
How it Works
RestoreU's patented technology identifies active risk factors and creates personalized care plans to address them
- conducts cognitive screening
- collects blood sample
- compiles health history
RestoreU’s patented AI:
- analyzes the data
- prioritizes the risk factors
- devises a care plan
- receives the results
- reviews the care plan
- recommends treatment
RestoreU care plans include
RestoreU’s AI pinpoints the status of all active factors and categorize them for physicians to systematically address.
Identified factors are shown in priority order, so factors with the most influence on cognitive health are at the top.
The status of your blood tests are provided to you with an explanation of how each marker contributes to cognitive decline. Please note, the RestoreU results are more sensitive than normal blood test ranges. RestoreU testing looks at status for optimal brain health.
The root cause of the following potential issues should be determined and addressed, before continuing with this RestoreU care plan. Physician should prioritize resolution of the six high-priority marked issues. Recommendations in this care plan should then be reviewed and applied within the context of steps to resolve these.
WHAT'S INSIDE OUR AI?
30 years of evidence from thousands of researchers showing disease progression can be halted including:
The artificial intelligence in the uMETHOD plan provides analysis of 50 drivers of patient cognitive status, equips me with a more precise diagnosis and offers a proactive treatment plan for my patients.
Dr. Ashish Sachdeva, MD
Early intervention is especially important, as recent estimates have found that more than 46 million Americans currently have preclinical AD.
Richard S. Isaacson, MD, Alzheimer’s Prevention Clinic at Weill Cornell Medicine and NewYork-Presbyterian
Instead of treating every patient the same, RestoreU provides an in-depth analysis into the factors associated with their cognitive issues and offers a personalized treatment plan for me to administer to the patient.
Federico Canavosio, MD, Integrative Medical Care, Vero Beach, FL
RestoreU is an entrée into multiple points of a patient’s care. Providers using RestoreU can broaden their treatment approach and address the complexities of dementia in a practical way to optimize health, specifically brain health.
Marwan Sabbagh, MD, FAAN, Barrow Neurological Institute, Phoenix, AZ
The complexity of Alzheimer’s disease and other forms of cognitive impairment make it difficult to manage in a primary care setting. I’m thankful RestoreU was brought to my attention as this is the best solution I’ve found to address memory loss for my patients.
Rodney Robert, MD, FAAFP, Decatur, TN